ATE464309T1 - Indolizinderivate und deren verwendung als crth2- antagonisten - Google Patents
Indolizinderivate und deren verwendung als crth2- antagonistenInfo
- Publication number
- ATE464309T1 ATE464309T1 AT06755627T AT06755627T ATE464309T1 AT E464309 T1 ATE464309 T1 AT E464309T1 AT 06755627 T AT06755627 T AT 06755627T AT 06755627 T AT06755627 T AT 06755627T AT E464309 T1 ATE464309 T1 AT E464309T1
- Authority
- AT
- Austria
- Prior art keywords
- c1c6alkyl
- hydrogen
- fully
- partially fluorinated
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0512944.0A GB0512944D0 (en) | 2005-06-24 | 2005-06-24 | Indolizine compounds |
PCT/GB2006/002341 WO2006136859A2 (en) | 2005-06-24 | 2006-06-26 | Indoli zine derivatives and their use as crth2 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE464309T1 true ATE464309T1 (de) | 2010-04-15 |
Family
ID=34856120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06755627T ATE464309T1 (de) | 2005-06-24 | 2006-06-26 | Indolizinderivate und deren verwendung als crth2- antagonisten |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090163534A1 (de) |
EP (1) | EP1910357B1 (de) |
JP (1) | JP2008543921A (de) |
CN (1) | CN101243086A (de) |
AT (1) | ATE464309T1 (de) |
DE (1) | DE602006013643D1 (de) |
GB (1) | GB0512944D0 (de) |
WO (1) | WO2006136859A2 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101411820B1 (ko) | 2006-08-07 | 2014-06-24 | 액테리온 파마슈티칼 리미티드 | (3-아미노-1,2,3,4-테트라하이드로-9h-카르바졸-9-일)-아세트산 유도체 |
JP2010513429A (ja) * | 2006-12-21 | 2010-04-30 | アージェンタ ディスカバリー リミテッド | Crth2アンタゴニスト |
GB0625842D0 (en) * | 2006-12-22 | 2007-02-07 | Argenta Discovery Ltd | Indolizine derivatives |
WO2008113965A1 (en) * | 2007-03-21 | 2008-09-25 | Argenta Discovery Limited | Indolizine acetic acid derivatives as crth2 antagonists |
US20100144786A1 (en) * | 2007-03-29 | 2010-06-10 | Michael Colin Cramp | Quinoline derivatives as crth2 receptor ligands |
TW200920373A (en) * | 2007-09-25 | 2009-05-16 | Actimis Pharmaceuticals Inc | 2-S-benzyl substituted pyrimidines as CRTH2 antagonists |
GB0719521D0 (en) * | 2007-10-05 | 2007-11-14 | Argenta Discovery Ltd | Compounds |
SI2327693T1 (sl) | 2007-12-14 | 2012-09-28 | Pulmagen Therapeutics Asthma Ltd Fulmer Hal Windmil Road | Indoli in njihova terapevtska raba |
US8101645B2 (en) * | 2008-02-15 | 2012-01-24 | Abbott Laboratories | Thienopyrroles and pyrrolothiazoles as new therapeutic agents |
EP2331541B1 (de) | 2008-09-04 | 2015-04-22 | Boehringer Ingelheim International GmbH | Indolizine als inhibitoren der leukotrienproduktion |
NZ591914A (en) | 2008-11-17 | 2013-04-26 | Hoffmann La Roche | Naphthylacetic acids |
AR077428A1 (es) | 2009-07-29 | 2011-08-24 | Sanofi Aventis | (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos |
BR112012024114B1 (pt) | 2010-03-22 | 2021-02-09 | Idorsia Pharmaceuticals Ltd | Compostos derivados de 3-(heteroarilamino)-1,2,3,4-tetrahidro-9h-carbazol, uso dos mesmos, e, composição farmacêutica |
EP2457900A1 (de) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten |
CN103459389B (zh) | 2011-04-14 | 2016-03-30 | 埃科特莱茵药品有限公司 | 7-(杂芳基-氨基)-6,7,8,9-四氢吡啶并[1,2-a]吲哚乙酸衍生物和其作为前列腺素D2受体调节剂的用途 |
WO2013088109A1 (en) | 2011-12-16 | 2013-06-20 | Oxagen Limited | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
PE20161177A1 (es) | 2014-03-17 | 2016-11-18 | Actelion Pharmaceuticals Ltd | Derivados del acido acetico azaindol y su uso como moduladores del receptor de prostaglandina d2 |
US9850241B2 (en) | 2014-03-18 | 2017-12-26 | Idorsia Pharmaceuticals Ltd | Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators |
TWI711616B (zh) | 2015-09-15 | 2020-12-01 | 瑞士商愛杜西亞製藥有限公司 | 結晶型式 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1174124A (en) * | 1967-06-30 | 1969-12-10 | Beecham Group Ltd | Pharmacologically Active Indolizine Compounds |
GB1268424A (en) * | 1969-10-04 | 1972-03-29 | Beecham Group Ltd | Indolizine derivatives |
ES421284A1 (es) * | 1973-12-07 | 1976-04-16 | Farmasimes S A | Procedimiento para la preparacion de derivados de acidos pirrocolinaceticos. |
CA2542716A1 (en) * | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds having crth2 antagonist activity |
WO2005040112A1 (en) * | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds with pgd2 antagonist activity |
GB0324763D0 (en) * | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
GB2407318A (en) * | 2003-10-23 | 2005-04-27 | Oxagen Ltd | Substituted Indol-3-yl acetic acid derivatives |
-
2005
- 2005-06-24 GB GBGB0512944.0A patent/GB0512944D0/en not_active Ceased
-
2006
- 2006-06-26 DE DE602006013643T patent/DE602006013643D1/de not_active Expired - Fee Related
- 2006-06-26 EP EP06755627A patent/EP1910357B1/de not_active Not-in-force
- 2006-06-26 WO PCT/GB2006/002341 patent/WO2006136859A2/en active Application Filing
- 2006-06-26 US US11/993,412 patent/US20090163534A1/en not_active Abandoned
- 2006-06-26 CN CNA2006800305874A patent/CN101243086A/zh active Pending
- 2006-06-26 AT AT06755627T patent/ATE464309T1/de not_active IP Right Cessation
- 2006-06-26 JP JP2008517604A patent/JP2008543921A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2006136859A3 (en) | 2007-04-05 |
US20090163534A1 (en) | 2009-06-25 |
EP1910357B1 (de) | 2010-04-14 |
DE602006013643D1 (de) | 2010-05-27 |
WO2006136859A2 (en) | 2006-12-28 |
JP2008543921A (ja) | 2008-12-04 |
CN101243086A (zh) | 2008-08-13 |
GB0512944D0 (en) | 2005-08-03 |
EP1910357A2 (de) | 2008-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE464309T1 (de) | Indolizinderivate und deren verwendung als crth2- antagonisten | |
MY177250A (en) | Novel nicotinamide derivative or salt thereof | |
CU20100021A7 (es) | Derivado de oxopirazina y herbicida | |
AR062409A1 (es) | Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto | |
RS51137B (sr) | Derivat benzimidazola i njegova upotreba kao antagonista receptora aii | |
TNSN06203A1 (en) | Derivatives of n- (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity | |
GB0510584D0 (en) | Organic compounds | |
GEP201706728B (en) | Noxious organism control agent | |
MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
RS51654B (en) | DERIVATIVES OF THE SUBSTITUTED BICYCLIC PIRIMIDONE | |
MY148988A (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
UA96947C2 (ru) | Производные циннамоил-пиперазина и их применение как антагонистов par-1 | |
ATE478054T1 (de) | Benzimidazolderivate | |
DE602005007064D1 (de) | Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors | |
MX2009012377A (es) | Compuestos de arilamida pirimidona. | |
WO2008155669A3 (en) | Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases | |
ATE488510T1 (de) | Heterocyclische derivate, deren herstellung und therapeutische verwendung | |
ATE548371T1 (de) | Tricyclische verbindung und deren medizinische verwendung | |
WO2008136388A1 (ja) | アミド化合物ならびにその植物病害防除用途 | |
NO20082436L (no) | Forbindelser med medisinske effekter grunnet interaksjonen med glukokortikoidreseptor | |
ATE414692T1 (de) | Pyridinketone mit herbizideffekt | |
CY1117348T1 (el) | Νεο παραγωγο φαινυλπυριδινης και φαρμακο που περιεχει αυτο | |
EA201070814A1 (ru) | Производные 6-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и их применение в терапии | |
CY1114798T1 (el) | Ενωσεις σουλφοναμιδιου για τη θεραπευτικη αντιμετωπιση αναπνευστικων διαταραχων | |
MX2010002585A (es) | Derivados de piperidina como antagonistas del receptor nk3. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |